Bradley Olwin
Concepts (400)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Satellite Cells, Skeletal Muscle | 17 | 2024 | 29 | 5.390 |
Why?
| Muscle, Skeletal | 32 | 2023 | 1642 | 3.790 |
Why?
| Muscle Development | 15 | 2022 | 103 | 2.720 |
Why?
| Muscle Fibers, Skeletal | 12 | 2024 | 190 | 2.460 |
Why?
| Regeneration | 15 | 2018 | 179 | 2.440 |
Why?
| Stem Cells | 9 | 2023 | 585 | 2.220 |
Why?
| Fibroblast Growth Factors | 23 | 2017 | 172 | 2.010 |
Why?
| Receptors, Fibroblast Growth Factor | 25 | 2001 | 65 | 1.330 |
Why?
| Cell Differentiation | 30 | 2022 | 1896 | 1.260 |
Why?
| MyoD Protein | 10 | 2015 | 32 | 1.130 |
Why?
| Syndecan-3 | 5 | 2016 | 7 | 1.080 |
Why?
| RNA Stability | 3 | 2016 | 101 | 1.030 |
Why?
| PAX7 Transcription Factor | 6 | 2024 | 13 | 0.980 |
Why?
| Stem Cell Niche | 2 | 2016 | 51 | 0.820 |
Why?
| Mice | 45 | 2024 | 16832 | 0.810 |
Why?
| Animals | 76 | 2024 | 35076 | 0.730 |
Why?
| Mitogen-Activated Protein Kinase 11 | 2 | 2014 | 3 | 0.700 |
Why?
| Mitogen-Activated Protein Kinase 14 | 2 | 2014 | 6 | 0.700 |
Why?
| Extremities | 9 | 2011 | 130 | 0.690 |
Why?
| Cell Nucleus | 1 | 2023 | 580 | 0.680 |
Why?
| RNA Processing, Post-Transcriptional | 2 | 2020 | 87 | 0.620 |
Why?
| Muscles | 14 | 2016 | 323 | 0.620 |
Why?
| Receptors, Cell Surface | 11 | 2011 | 380 | 0.610 |
Why?
| Muscle, Striated | 1 | 2018 | 6 | 0.590 |
Why?
| Cell Separation | 2 | 2017 | 317 | 0.590 |
Why?
| Lipoprotein Lipase | 1 | 2018 | 59 | 0.570 |
Why?
| Signal Transduction | 17 | 2017 | 4930 | 0.560 |
Why?
| Pluripotent Stem Cells | 1 | 2018 | 78 | 0.560 |
Why?
| Teratoma | 1 | 2018 | 103 | 0.560 |
Why?
| Fluorescent Antibody Technique | 4 | 2016 | 393 | 0.550 |
Why?
| Fibroblast Growth Factor 2 | 9 | 1998 | 85 | 0.550 |
Why?
| Stem Cell Transplantation | 2 | 2017 | 167 | 0.520 |
Why?
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 278 | 0.500 |
Why?
| Genetic Therapy | 1 | 2018 | 296 | 0.500 |
Why?
| Homeostasis | 2 | 2016 | 613 | 0.500 |
Why?
| Cell Division | 14 | 2004 | 802 | 0.500 |
Why?
| Chick Embryo | 15 | 2011 | 130 | 0.490 |
Why?
| Tristetraprolin | 1 | 2015 | 5 | 0.490 |
Why?
| Myoblasts | 6 | 2021 | 80 | 0.480 |
Why?
| Fibroblast Growth Factor 1 | 5 | 2014 | 12 | 0.470 |
Why?
| Cell Culture Techniques | 2 | 2023 | 352 | 0.470 |
Why?
| Cell Transplantation | 2 | 2014 | 35 | 0.470 |
Why?
| Cell Cycle | 5 | 2010 | 587 | 0.460 |
Why?
| Cell Proliferation | 9 | 2016 | 2381 | 0.460 |
Why?
| Proteoglycans | 4 | 2004 | 110 | 0.460 |
Why?
| RNA, Messenger | 4 | 2018 | 2732 | 0.460 |
Why?
| Cell Line | 19 | 2012 | 2786 | 0.430 |
Why?
| Receptors, Notch | 2 | 2012 | 87 | 0.430 |
Why?
| ATP-Binding Cassette Transporters | 2 | 2011 | 130 | 0.430 |
Why?
| Syndecan-4 | 3 | 2009 | 7 | 0.430 |
Why?
| Cellular Senescence | 2 | 2015 | 177 | 0.420 |
Why?
| Asymmetric Cell Division | 1 | 2012 | 2 | 0.410 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 290 | 0.400 |
Why?
| Mechanotransduction, Cellular | 2 | 2024 | 111 | 0.390 |
Why?
| Heparitin Sulfate | 5 | 2001 | 44 | 0.380 |
Why?
| Hedgehog Proteins | 2 | 2011 | 189 | 0.380 |
Why?
| Down Syndrome | 1 | 2018 | 469 | 0.370 |
Why?
| Cell Adhesion Molecules | 1 | 2012 | 177 | 0.370 |
Why?
| Avian Proteins | 1 | 2011 | 20 | 0.370 |
Why?
| Neoplasms, Muscle Tissue | 1 | 2011 | 5 | 0.370 |
Why?
| Rhabdomyosarcoma, Alveolar | 1 | 2011 | 10 | 0.370 |
Why?
| Cysteine | 4 | 1997 | 192 | 0.360 |
Why?
| Membrane Glycoproteins | 3 | 2004 | 476 | 0.360 |
Why?
| ras Proteins | 2 | 2002 | 151 | 0.350 |
Why?
| Forkhead Transcription Factors | 1 | 2011 | 183 | 0.340 |
Why?
| Cells, Cultured | 15 | 2018 | 4106 | 0.330 |
Why?
| Retroviridae | 5 | 2018 | 97 | 0.330 |
Why?
| Oncogene Proteins, Fusion | 1 | 2011 | 198 | 0.320 |
Why?
| Aging | 6 | 2023 | 1785 | 0.320 |
Why?
| Transfection | 8 | 2016 | 910 | 0.310 |
Why?
| Receptor Protein-Tyrosine Kinases | 3 | 2001 | 237 | 0.310 |
Why?
| Calmodulin | 8 | 1985 | 75 | 0.310 |
Why?
| Gene Expression | 5 | 2023 | 1487 | 0.300 |
Why?
| Muscular Diseases | 2 | 2020 | 110 | 0.290 |
Why?
| RNA-Binding Proteins | 3 | 2022 | 388 | 0.290 |
Why?
| Mice, Knockout | 4 | 2018 | 2811 | 0.280 |
Why?
| Myogenin | 4 | 2012 | 13 | 0.280 |
Why?
| Isoenzymes | 2 | 2012 | 305 | 0.270 |
Why?
| Hydrogels | 2 | 2024 | 637 | 0.270 |
Why?
| Protein Kinase C | 2 | 2012 | 258 | 0.260 |
Why?
| Adult Stem Cells | 2 | 2017 | 37 | 0.260 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2011 | 1341 | 0.240 |
Why?
| Adaptor Proteins, Signal Transducing | 2 | 2021 | 398 | 0.230 |
Why?
| Mice, Inbred C57BL | 5 | 2018 | 5365 | 0.230 |
Why?
| Base Sequence | 9 | 2015 | 2162 | 0.220 |
Why?
| Integrins | 1 | 2024 | 94 | 0.220 |
Why?
| Elasticity | 1 | 2024 | 202 | 0.220 |
Why?
| Molecular Sequence Data | 10 | 2015 | 2854 | 0.210 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2002 | 316 | 0.200 |
Why?
| Trans-Activators | 2 | 2021 | 387 | 0.200 |
Why?
| Homeodomain Proteins | 2 | 2004 | 495 | 0.200 |
Why?
| Gene Expression Regulation | 4 | 2007 | 2549 | 0.190 |
Why?
| Enzyme Activation | 5 | 2012 | 817 | 0.190 |
Why?
| Genetic Vectors | 3 | 2018 | 314 | 0.190 |
Why?
| Microscopy | 1 | 2023 | 140 | 0.190 |
Why?
| Flow Cytometry | 2 | 2017 | 1158 | 0.190 |
Why?
| Binding Sites | 6 | 2015 | 1252 | 0.180 |
Why?
| Models, Biological | 3 | 2018 | 1716 | 0.180 |
Why?
| Mesoderm | 5 | 1995 | 139 | 0.170 |
Why?
| Muscle Proteins | 4 | 1996 | 228 | 0.170 |
Why?
| Cell Membrane | 5 | 2010 | 732 | 0.170 |
Why?
| Contracture | 1 | 2020 | 24 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2001 | 187 | 0.170 |
Why?
| Education | 1 | 2020 | 99 | 0.160 |
Why?
| Research Report | 1 | 2020 | 76 | 0.160 |
Why?
| Receptors, Platelet-Derived Growth Factor | 2 | 1998 | 14 | 0.160 |
Why?
| Genes, Reporter | 4 | 2002 | 271 | 0.160 |
Why?
| Neuromuscular Diseases | 1 | 2020 | 106 | 0.160 |
Why?
| Musculoskeletal Diseases | 1 | 2020 | 69 | 0.160 |
Why?
| Cell Survival | 3 | 2012 | 1098 | 0.160 |
Why?
| TDP-43 Proteinopathies | 1 | 2018 | 4 | 0.160 |
Why?
| Virulence Factors, Bordetella | 1 | 1998 | 19 | 0.160 |
Why?
| Pertussis Toxin | 1 | 1998 | 26 | 0.160 |
Why?
| Protein Binding | 11 | 2015 | 2120 | 0.150 |
Why?
| Protein-Tyrosine Kinases | 2 | 2001 | 429 | 0.150 |
Why?
| GTP-Binding Proteins | 1 | 1998 | 157 | 0.150 |
Why?
| Amyloid | 1 | 2018 | 84 | 0.150 |
Why?
| 3' Untranslated Regions | 2 | 2016 | 138 | 0.150 |
Why?
| Recombinant Proteins | 8 | 2016 | 1314 | 0.140 |
Why?
| Ubiquitin Thiolesterase | 1 | 2018 | 42 | 0.140 |
Why?
| Hypertriglyceridemia | 1 | 2018 | 39 | 0.140 |
Why?
| Muscular Dystrophies | 2 | 2010 | 39 | 0.140 |
Why?
| MAP Kinase Signaling System | 2 | 2012 | 311 | 0.140 |
Why?
| Nervous System Diseases | 1 | 2020 | 260 | 0.140 |
Why?
| Platelet-Derived Growth Factor | 2 | 1995 | 91 | 0.140 |
Why?
| Cell Self Renewal | 1 | 2017 | 55 | 0.140 |
Why?
| Heterogeneous-Nuclear Ribonucleoprotein D | 1 | 2016 | 3 | 0.130 |
Why?
| Growth Differentiation Factors | 1 | 2016 | 1 | 0.130 |
Why?
| Biomarkers | 3 | 2017 | 3923 | 0.130 |
Why?
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2001 | 52 | 0.120 |
Why?
| DNA Damage | 1 | 2018 | 379 | 0.120 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2015 | 35 | 0.120 |
Why?
| Mice, Mutant Strains | 3 | 2004 | 295 | 0.120 |
Why?
| Bone Morphogenetic Proteins | 1 | 2016 | 132 | 0.120 |
Why?
| Phenotype | 3 | 2014 | 3084 | 0.120 |
Why?
| Wings, Animal | 2 | 1995 | 41 | 0.120 |
Why?
| Heparin | 5 | 2001 | 252 | 0.120 |
Why?
| Humans | 22 | 2023 | 130305 | 0.120 |
Why?
| Calcium | 5 | 1985 | 1189 | 0.120 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2015 | 158 | 0.110 |
Why?
| Mice, Inbred DBA | 1 | 2014 | 183 | 0.110 |
Why?
| Laminin | 2 | 2001 | 70 | 0.110 |
Why?
| Calmodulin-Binding Proteins | 5 | 1985 | 12 | 0.110 |
Why?
| Heparan Sulfate Proteoglycans | 3 | 2001 | 21 | 0.100 |
Why?
| RNA, Small Interfering | 1 | 2015 | 586 | 0.100 |
Why?
| Gene Expression Regulation, Developmental | 4 | 2015 | 825 | 0.100 |
Why?
| Extracellular Matrix Proteins | 1 | 1994 | 146 | 0.100 |
Why?
| Muscle Cells | 1 | 2012 | 41 | 0.100 |
Why?
| Molecular Weight | 6 | 1991 | 333 | 0.100 |
Why?
| Chlorates | 3 | 2001 | 4 | 0.100 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 431 | 0.100 |
Why?
| Environment | 1 | 2014 | 347 | 0.100 |
Why?
| DNA-Binding Proteins | 2 | 2018 | 1433 | 0.100 |
Why?
| Ligands | 1 | 2014 | 624 | 0.100 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 773 | 0.090 |
Why?
| Patched Receptors | 1 | 2011 | 12 | 0.090 |
Why?
| Immunohistochemistry | 4 | 2002 | 1711 | 0.090 |
Why?
| Butadienes | 2 | 2002 | 35 | 0.090 |
Why?
| Fibroblasts | 2 | 2000 | 953 | 0.090 |
Why?
| Multiprotein Complexes | 1 | 2012 | 149 | 0.090 |
Why?
| Forkhead Box Protein O1 | 1 | 2011 | 21 | 0.090 |
Why?
| Transduction, Genetic | 1 | 2011 | 129 | 0.090 |
Why?
| Nitriles | 2 | 2002 | 162 | 0.090 |
Why?
| Cattle | 9 | 1993 | 981 | 0.090 |
Why?
| Kinetics | 11 | 1988 | 1634 | 0.090 |
Why?
| Protein Structure, Tertiary | 2 | 2007 | 842 | 0.090 |
Why?
| Female | 8 | 2018 | 68842 | 0.090 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2010 | 26 | 0.090 |
Why?
| Cricetinae | 4 | 1997 | 278 | 0.090 |
Why?
| Embryonic and Fetal Development | 1 | 1990 | 96 | 0.080 |
Why?
| Mice, Inbred Strains | 1 | 2010 | 408 | 0.080 |
Why?
| Mice, Transgenic | 1 | 2015 | 2107 | 0.080 |
Why?
| Graft Survival | 1 | 2012 | 543 | 0.080 |
Why?
| Binding, Competitive | 4 | 1997 | 208 | 0.080 |
Why?
| Transcription, Genetic | 3 | 2011 | 1415 | 0.080 |
Why?
| Naphthalenesulfonates | 3 | 1984 | 7 | 0.080 |
Why?
| Electrophoresis, Polyacrylamide Gel | 5 | 1990 | 327 | 0.080 |
Why?
| Drosophila melanogaster | 1 | 1991 | 218 | 0.080 |
Why?
| Green Fluorescent Proteins | 1 | 2010 | 394 | 0.080 |
Why?
| Cell Cycle Proteins | 1 | 2012 | 585 | 0.080 |
Why?
| Cartilage | 3 | 1995 | 181 | 0.080 |
Why?
| Extracellular Matrix | 3 | 2000 | 500 | 0.080 |
Why?
| Proto-Oncogene Proteins | 3 | 2000 | 645 | 0.070 |
Why?
| Enzyme Inhibitors | 2 | 2002 | 832 | 0.070 |
Why?
| Hindlimb | 2 | 2002 | 127 | 0.070 |
Why?
| DNA Primers | 4 | 2002 | 523 | 0.070 |
Why?
| Polysaccharide-Lyases | 3 | 1992 | 11 | 0.070 |
Why?
| Receptor, Platelet-Derived Growth Factor beta | 2 | 1998 | 30 | 0.070 |
Why?
| Phosphoprotein Phosphatases | 2 | 1984 | 67 | 0.070 |
Why?
| Calcium-Binding Proteins | 3 | 1982 | 215 | 0.070 |
Why?
| CHO Cells | 3 | 1997 | 152 | 0.070 |
Why?
| Protein Interaction Mapping | 1 | 2007 | 109 | 0.070 |
Why?
| Tissue Engineering | 1 | 2010 | 391 | 0.070 |
Why?
| DNA | 4 | 1998 | 1412 | 0.070 |
Why?
| Protein Kinases | 2 | 1986 | 307 | 0.060 |
Why?
| Embryo, Mammalian | 2 | 2001 | 227 | 0.060 |
Why?
| Troponin | 2 | 1982 | 50 | 0.060 |
Why?
| ErbB Receptors | 1 | 1988 | 611 | 0.060 |
Why?
| Ectoderm | 3 | 1994 | 50 | 0.060 |
Why?
| Calcium Chloride | 1 | 1984 | 14 | 0.060 |
Why?
| Mitosis | 2 | 2001 | 179 | 0.060 |
Why?
| Time Factors | 3 | 2014 | 6615 | 0.060 |
Why?
| Viscosity | 1 | 2024 | 91 | 0.060 |
Why?
| Carbohydrate Sequence | 2 | 1994 | 24 | 0.060 |
Why?
| Amino Acid Sequence | 5 | 1997 | 2060 | 0.060 |
Why?
| Myosin Heavy Chains | 1 | 2005 | 174 | 0.060 |
Why?
| RNA | 2 | 2020 | 887 | 0.050 |
Why?
| Azirines | 1 | 1982 | 2 | 0.050 |
Why?
| Dansyl Compounds | 1 | 1982 | 5 | 0.050 |
Why?
| Aziridines | 1 | 1982 | 5 | 0.050 |
Why?
| Male | 5 | 2018 | 63748 | 0.050 |
Why?
| Oligopeptides | 1 | 2024 | 258 | 0.050 |
Why?
| Glycosaminoglycans | 2 | 1994 | 85 | 0.050 |
Why?
| Blotting, Western | 1 | 2004 | 1201 | 0.050 |
Why?
| Forelimb | 1 | 2001 | 28 | 0.050 |
Why?
| Carbazoles | 1 | 2002 | 85 | 0.050 |
Why?
| Suramin | 1 | 2001 | 7 | 0.050 |
Why?
| Alternative Splicing | 2 | 2020 | 219 | 0.050 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 2001 | 45 | 0.050 |
Why?
| Autocrine Communication | 1 | 2001 | 45 | 0.050 |
Why?
| Cell Fusion | 1 | 2001 | 51 | 0.050 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2001 | 75 | 0.050 |
Why?
| MAP Kinase Kinase 2 | 1 | 2001 | 28 | 0.050 |
Why?
| S Phase | 1 | 2001 | 73 | 0.040 |
Why?
| G1 Phase | 1 | 2001 | 71 | 0.040 |
Why?
| MAP Kinase Kinase 1 | 1 | 2001 | 76 | 0.040 |
Why?
| Flavonoids | 1 | 2001 | 79 | 0.040 |
Why?
| Myogenic Regulatory Factors | 1 | 2000 | 56 | 0.040 |
Why?
| Chickens | 2 | 2000 | 188 | 0.040 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 130 | 0.040 |
Why?
| Spectrometry, Fluorescence | 4 | 1985 | 171 | 0.040 |
Why?
| Polyadenylation | 1 | 2020 | 40 | 0.040 |
Why?
| Somites | 1 | 2000 | 5 | 0.040 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 157 | 0.040 |
Why?
| Chicago | 1 | 2020 | 52 | 0.040 |
Why?
| Transcription Factors | 2 | 2021 | 1649 | 0.040 |
Why?
| Species Specificity | 2 | 2012 | 571 | 0.040 |
Why?
| Autoradiography | 2 | 1990 | 76 | 0.040 |
Why?
| DNA Replication | 3 | 1992 | 228 | 0.040 |
Why?
| Fluorescent Dyes | 4 | 1985 | 319 | 0.040 |
Why?
| Biocompatible Materials | 1 | 2023 | 395 | 0.040 |
Why?
| Animals, Newborn | 1 | 2001 | 822 | 0.040 |
Why?
| Body Patterning | 1 | 2000 | 128 | 0.040 |
Why?
| Muscular Dystrophy, Duchenne | 1 | 2020 | 94 | 0.040 |
Why?
| Indoles | 1 | 2002 | 379 | 0.040 |
Why?
| Cholera Toxin | 1 | 1998 | 29 | 0.040 |
Why?
| Colforsin | 1 | 1998 | 51 | 0.040 |
Why?
| Thionucleotides | 1 | 1998 | 34 | 0.040 |
Why?
| Promoter Regions, Genetic | 2 | 2010 | 1207 | 0.040 |
Why?
| Cross-Linking Reagents | 2 | 1989 | 205 | 0.040 |
Why?
| Fibrinolytic Agents | 1 | 2001 | 264 | 0.040 |
Why?
| Sarcomeres | 1 | 2018 | 92 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 1 | 1998 | 139 | 0.040 |
Why?
| Cerebral Palsy | 1 | 2020 | 96 | 0.040 |
Why?
| Polyethylene Glycols | 1 | 2023 | 601 | 0.040 |
Why?
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 69 | 0.040 |
Why?
| Cytoplasm | 1 | 2018 | 263 | 0.040 |
Why?
| Tyrosine | 1 | 1998 | 220 | 0.040 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 48 | 0.030 |
Why?
| Carrier Proteins | 3 | 1991 | 738 | 0.030 |
Why?
| Proteins | 1 | 2023 | 948 | 0.030 |
Why?
| Subcellular Fractions | 1 | 1997 | 80 | 0.030 |
Why?
| Bone and Bones | 1 | 2000 | 303 | 0.030 |
Why?
| Cell Movement | 1 | 2001 | 948 | 0.030 |
Why?
| Fluorescence Polarization | 4 | 1985 | 38 | 0.030 |
Why?
| Golgi Apparatus | 1 | 1997 | 100 | 0.030 |
Why?
| Iodine Radioisotopes | 1 | 1997 | 142 | 0.030 |
Why?
| Myocardium | 2 | 2016 | 989 | 0.030 |
Why?
| Parabiosis | 1 | 2016 | 11 | 0.030 |
Why?
| Thermodynamics | 3 | 1984 | 408 | 0.030 |
Why?
| Myostatin | 1 | 2016 | 18 | 0.030 |
Why?
| Smad3 Protein | 1 | 2016 | 44 | 0.030 |
Why?
| Fibroblast Growth Factor 4 | 2 | 1993 | 19 | 0.030 |
Why?
| Cloning, Molecular | 2 | 1998 | 536 | 0.030 |
Why?
| Smad2 Protein | 1 | 2016 | 37 | 0.030 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2016 | 121 | 0.030 |
Why?
| Receptors, Growth Factor | 1 | 1995 | 55 | 0.030 |
Why?
| Salamandridae | 1 | 1995 | 26 | 0.030 |
Why?
| Biological Transport | 1 | 1997 | 397 | 0.030 |
Why?
| Hypertrophy | 1 | 2016 | 120 | 0.030 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2015 | 14 | 0.030 |
Why?
| Drug Evaluation, Preclinical | 1 | 2016 | 174 | 0.030 |
Why?
| Second Messenger Systems | 1 | 1995 | 32 | 0.030 |
Why?
| Single-Blind Method | 1 | 2016 | 274 | 0.030 |
Why?
| Gene Deletion | 1 | 1997 | 377 | 0.030 |
Why?
| Phosphorylation | 2 | 1998 | 1709 | 0.030 |
Why?
| Ubiquitination | 1 | 2015 | 99 | 0.030 |
Why?
| Cachexia | 1 | 2016 | 60 | 0.030 |
Why?
| Nucleic Acid Conformation | 1 | 1998 | 706 | 0.030 |
Why?
| Brain | 5 | 1990 | 2629 | 0.030 |
Why?
| Carbohydrate Conformation | 1 | 1994 | 15 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2015 | 146 | 0.030 |
Why?
| Models, Animal | 1 | 2016 | 373 | 0.030 |
Why?
| MicroRNAs | 1 | 2020 | 680 | 0.030 |
Why?
| Aggrecans | 1 | 1994 | 14 | 0.030 |
Why?
| Olfactory Receptor Neurons | 1 | 1994 | 70 | 0.030 |
Why?
| Chondroitin Sulfates | 1 | 1994 | 34 | 0.030 |
Why?
| Lectins, C-Type | 1 | 1994 | 70 | 0.030 |
Why?
| Actins | 1 | 1996 | 409 | 0.030 |
Why?
| Brain Chemistry | 1 | 1994 | 116 | 0.030 |
Why?
| In Vitro Techniques | 2 | 1994 | 1067 | 0.030 |
Why?
| Recombinant Fusion Proteins | 1 | 1996 | 645 | 0.030 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 1983 | 11 | 0.030 |
Why?
| Protein Sorting Signals | 1 | 1992 | 19 | 0.030 |
Why?
| N-Glycosyl Hydrolases | 1 | 1992 | 6 | 0.030 |
Why?
| Genetic Techniques | 1 | 1993 | 65 | 0.030 |
Why?
| Gene Expression Regulation, Viral | 1 | 1993 | 91 | 0.030 |
Why?
| Osteogenesis | 1 | 1994 | 197 | 0.020 |
Why?
| Sulfates | 1 | 1992 | 49 | 0.020 |
Why?
| Immunotoxins | 1 | 1992 | 51 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2012 | 190 | 0.020 |
Why?
| Rabbits | 2 | 1984 | 766 | 0.020 |
Why?
| Structure-Activity Relationship | 2 | 1991 | 541 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 1992 | 373 | 0.020 |
Why?
| Heart | 1 | 2016 | 654 | 0.020 |
Why?
| Arterial Occlusive Diseases | 1 | 1992 | 80 | 0.020 |
Why?
| Mice, SCID | 1 | 2012 | 349 | 0.020 |
Why?
| Angioplasty, Balloon | 1 | 1992 | 90 | 0.020 |
Why?
| Dogs | 1 | 2012 | 377 | 0.020 |
Why?
| Cell Communication | 1 | 2012 | 299 | 0.020 |
Why?
| Mice, Inbred mdx | 1 | 2010 | 11 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 1992 | 410 | 0.020 |
Why?
| Chromatography, High Pressure Liquid | 2 | 1989 | 491 | 0.020 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1989 | 7 | 0.020 |
Why?
| Succinimides | 1 | 1989 | 16 | 0.020 |
Why?
| Chromatography, Affinity | 1 | 1989 | 83 | 0.020 |
Why?
| Mutation | 2 | 2000 | 3723 | 0.020 |
Why?
| Amidohydrolases | 1 | 1989 | 30 | 0.020 |
Why?
| Aorta | 1 | 1992 | 416 | 0.020 |
Why?
| Muscle, Smooth, Vascular | 1 | 1992 | 437 | 0.020 |
Why?
| Oligosaccharides | 1 | 1989 | 57 | 0.020 |
Why?
| Immunity | 1 | 2010 | 137 | 0.020 |
Why?
| Eye | 1 | 1990 | 104 | 0.020 |
Why?
| Tissue Distribution | 1 | 1989 | 297 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2016 | 3069 | 0.020 |
Why?
| Immunoglobulin G | 1 | 2012 | 845 | 0.020 |
Why?
| Phosphoric Diester Hydrolases | 2 | 1985 | 46 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 1989 | 549 | 0.020 |
Why?
| Muscle, Smooth | 1 | 1988 | 155 | 0.020 |
Why?
| Liver | 2 | 1990 | 1846 | 0.020 |
Why?
| Immunosorbent Techniques | 1 | 1985 | 19 | 0.020 |
Why?
| Aminoquinolines | 1 | 1985 | 21 | 0.020 |
Why?
| Immunologic Techniques | 1 | 1985 | 39 | 0.020 |
Why?
| Rats | 3 | 1992 | 5285 | 0.020 |
Why?
| Receptors, Cholinergic | 1 | 1985 | 38 | 0.020 |
Why?
| DNA, Complementary | 2 | 1995 | 271 | 0.020 |
Why?
| Troponin I | 2 | 1982 | 75 | 0.010 |
Why?
| Methionine | 1 | 1985 | 159 | 0.010 |
Why?
| Adenylyl Cyclases | 1 | 1985 | 83 | 0.010 |
Why?
| Myosin-Light-Chain Kinase | 1 | 1984 | 20 | 0.010 |
Why?
| 3T3 Cells | 2 | 1995 | 152 | 0.010 |
Why?
| Membrane Proteins | 1 | 1991 | 1121 | 0.010 |
Why?
| Myofibrils | 1 | 1984 | 50 | 0.010 |
Why?
| Horseshoe Crabs | 1 | 1983 | 2 | 0.010 |
Why?
| Phosphatidylcholines | 1 | 1985 | 148 | 0.010 |
Why?
| L-Lactate Dehydrogenase | 1 | 1983 | 118 | 0.010 |
Why?
| Liposomes | 1 | 1985 | 171 | 0.010 |
Why?
| Mathematics | 1 | 1984 | 103 | 0.010 |
Why?
| Age Factors | 1 | 1991 | 3153 | 0.010 |
Why?
| Biological Assay | 2 | 1994 | 118 | 0.010 |
Why?
| Adenylyl Cyclase Inhibitors | 1 | 1980 | 6 | 0.010 |
Why?
| Homozygote | 1 | 2000 | 192 | 0.010 |
Why?
| COS Cells | 1 | 2000 | 185 | 0.010 |
Why?
| Templates, Genetic | 1 | 1998 | 61 | 0.010 |
Why?
| Adenosine Triphosphate | 1 | 1980 | 483 | 0.010 |
Why?
| Cerebral Cortex | 1 | 1980 | 419 | 0.010 |
Why?
| Limb Buds | 1 | 1995 | 22 | 0.010 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1995 | 24 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1995 | 298 | 0.010 |
Why?
| MSX1 Transcription Factor | 1 | 1994 | 5 | 0.010 |
Why?
| Olfactory Mucosa | 1 | 1994 | 68 | 0.010 |
Why?
| Genes, Homeobox | 1 | 1994 | 52 | 0.010 |
Why?
| Antibody Specificity | 1 | 1993 | 186 | 0.010 |
Why?
| Limb Deformities, Congenital | 1 | 1993 | 12 | 0.010 |
Why?
| Ribosome Inactivating Proteins, Type 1 | 1 | 1992 | 3 | 0.010 |
Why?
| Cell Death | 1 | 1994 | 353 | 0.010 |
Why?
| Rats, Inbred Strains | 1 | 1992 | 366 | 0.010 |
Why?
| Morphogenesis | 1 | 1993 | 159 | 0.010 |
Why?
| Plant Proteins | 1 | 1992 | 93 | 0.010 |
Why?
| Magnesium | 2 | 1982 | 151 | 0.010 |
Why?
| Mice, Inbred BALB C | 1 | 1993 | 1245 | 0.010 |
Why?
| Antibodies | 1 | 1992 | 398 | 0.010 |
Why?
| Interphase | 1 | 1987 | 31 | 0.000 |
Why?
| Peptides | 1 | 1992 | 917 | 0.000 |
Why?
| Guanosine Triphosphate | 1 | 1986 | 92 | 0.000 |
Why?
| Ribosomal Proteins | 1 | 1986 | 76 | 0.000 |
Why?
| Macromolecular Substances | 1 | 1986 | 212 | 0.000 |
Why?
| Stereoisomerism | 1 | 1983 | 100 | 0.000 |
Why?
| Substrate Specificity | 1 | 1983 | 373 | 0.000 |
Why?
| Magnesium Chloride | 1 | 1982 | 7 | 0.000 |
Why?
| Potassium Chloride | 1 | 1982 | 34 | 0.000 |
Why?
| Fatty Acids | 1 | 1985 | 416 | 0.000 |
Why?
| Temperature | 1 | 1985 | 636 | 0.000 |
Why?
| Chromatography, Gel | 1 | 1982 | 127 | 0.000 |
Why?
| Osmolar Concentration | 1 | 1982 | 166 | 0.000 |
Why?
| Edetic Acid | 1 | 1980 | 47 | 0.000 |
Why?
| Manganese | 1 | 1980 | 61 | 0.000 |
Why?
| Biological Evolution | 1 | 1983 | 428 | 0.000 |
Why?
| Peptide Fragments | 1 | 1983 | 698 | 0.000 |
Why?
| Protein Conformation | 1 | 1981 | 857 | 0.000 |
Why?
|
|
Olwin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|